Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting | PLOS ONE
![Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation | Radiation Oncology | Full Text Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation | Radiation Oncology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13014-017-0884-y/MediaObjects/13014_2017_884_Fig2_HTML.gif)
Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation | Radiation Oncology | Full Text
![Cancers | Free Full-Text | Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction Cancers | Free Full-Text | Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction](https://pub.mdpi-res.com/cancers/cancers-13-03381/article_deploy/html/images/cancers-13-03381-g001.png?1625729802)
Cancers | Free Full-Text | Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction
![Résultats de la lymphadénectomie de sauvetage dans une population spécifique atteinte d'un cancer de la prostate présentant une récidive biochimique avec TEP-Choline négative mais TEP/TD 68Ga-PSMA positive - ScienceDirect Résultats de la lymphadénectomie de sauvetage dans une population spécifique atteinte d'un cancer de la prostate présentant une récidive biochimique avec TEP-Choline négative mais TEP/TD 68Ga-PSMA positive - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1166708720303286-fx1.jpg)
Résultats de la lymphadénectomie de sauvetage dans une population spécifique atteinte d'un cancer de la prostate présentant une récidive biochimique avec TEP-Choline négative mais TEP/TD 68Ga-PSMA positive - ScienceDirect
![Cureus | Association of Nadir Prostate-specific Antigen >0.5 ng/mL after Dose-escalated External Beam Radiation with Prostate Cancer-specific Endpoints | Article Cureus | Association of Nadir Prostate-specific Antigen >0.5 ng/mL after Dose-escalated External Beam Radiation with Prostate Cancer-specific Endpoints | Article](https://assets.cureus.com/uploads/figure/file/29242/a099e0804c6f11e883b9bd01db8ff489-Figure1.png)
Cureus | Association of Nadir Prostate-specific Antigen >0.5 ng/mL after Dose-escalated External Beam Radiation with Prostate Cancer-specific Endpoints | Article
![Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/12aed22c0affb1decf9e7953f12f3a9fb0849553/22-Table2-1.png)
Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar
![Prepayment Modeling with a Two Factor Hull White Model and a LIBOR Market Model - MATLAB & Simulink - MathWorks France Prepayment Modeling with a Two Factor Hull White Model and a LIBOR Market Model - MATLAB & Simulink - MathWorks France](https://fr.mathworks.com/help/examples/fininst/win64/Demo_Prepayment_01.png)
Prepayment Modeling with a Two Factor Hull White Model and a LIBOR Market Model - MATLAB & Simulink - MathWorks France
![PSA response to antiandrogen withdrawal: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases PSA response to antiandrogen withdrawal: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41391-021-00337-0/MediaObjects/41391_2021_337_Fig2_HTML.png)
PSA response to antiandrogen withdrawal: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases
![Diagnostics | Free Full-Text | Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic Castration Resistant Prostate Cancer: A ... Diagnostics | Free Full-Text | Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic Castration Resistant Prostate Cancer: A ...](https://www.mdpi.com/diagnostics/diagnostics-11-00663/article_deploy/html/images/diagnostics-11-00663-g006.png)
Diagnostics | Free Full-Text | Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic Castration Resistant Prostate Cancer: A ...
![Initial Experience of Lung Metastases Response to 225Ac-PSMA-617 Therapy in Metastatic Prostate Adenocarcinoma | Journal of Nuclear Medicine Initial Experience of Lung Metastases Response to 225Ac-PSMA-617 Therapy in Metastatic Prostate Adenocarcinoma | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/63/supplement_2/2550/F1.large.jpg)
Initial Experience of Lung Metastases Response to 225Ac-PSMA-617 Therapy in Metastatic Prostate Adenocarcinoma | Journal of Nuclear Medicine
![Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/fbc9fb93-c826-43a7-b92a-ac0d1359335c/gr1_lrg.jpg)
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine
![Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less. Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less.](https://d3i71xaburhd42.cloudfront.net/bbc5bbcef53a29466addccfb1a86dca2e6a5abe5/2-Table1-1.png)